Cardiomatics is a cloud-based AI platform that enables medical professionals to analyze electrocardiograms (ECGs) quickly and accurately. By using artificial intelligence, Cardiomatics automates the detection of cardiac conditions such as arrhythmias, atrial fibrillation, and heart rate variability issues. The platform is designed to support cardiologists, general practitioners, and healthcare institutions in delivering faster and more reliable diagnoses.
Founded in 2018 and headquartered in Poland, Cardiomatics serves clients across Europe and beyond. It is CE-certified as a Class IIa medical device under the Medical Device Regulation (MDR), indicating high standards of clinical safety and accuracy. The platform integrates seamlessly with various ECG recording devices and allows healthcare providers to analyze ECG data without the need for complex software or manual interpretation.
Features
Cardiomatics offers several advanced features to simplify and speed up ECG interpretation. The platform supports automated ECG analysis with over 140 clinically validated parameters, including detection of atrial fibrillation, bradycardia, tachycardia, pauses, and premature contractions.
The platform generates a comprehensive ECG report within minutes of data upload. The report includes visual graphs, beat annotations, arrhythmia summaries, and statistical insights to help clinicians make informed decisions.
Cardiomatics is device-agnostic, meaning it works with most Holter monitors and ECG devices available on the market. Users can upload data in formats like EDF, HL7, or DICOM and receive consistent results regardless of the device used.
The platform is hosted in a secure cloud environment compliant with GDPR and ISO 27001, ensuring full data protection and privacy. Clinicians can access the platform via any web browser, with no software installation required.
Additionally, Cardiomatics offers a collaborative interface where healthcare teams can review, annotate, and share results for second opinions or interdisciplinary consultations.
How It Works
To use Cardiomatics, a healthcare professional records a patient’s ECG using a compatible device. Once the recording is complete, the ECG file is uploaded to the Cardiomatics platform via a secure web portal.
After upload, the platform’s AI engine processes the data, analyzing every heartbeat and detecting abnormal patterns. The system uses machine learning algorithms trained on millions of ECG records to identify conditions such as atrial fibrillation, supraventricular tachycardia, ventricular ectopy, and more.
Within minutes, a detailed report is generated and made available for review. The clinician can download the report, share it securely, or integrate it into the patient’s electronic health record.
The entire process—from upload to diagnosis—can be completed in significantly less time than traditional manual ECG interpretation, reducing delays in diagnosis and treatment.
Use Cases
Cardiomatics is ideal for primary care clinics that want to offer ECG analysis without hiring in-house cardiologists. GPs can record Holter data and receive AI-generated reports to support referral decisions.
In cardiology practices, the platform serves as a decision-support tool, providing faster insights and reducing workload for cardiologists who need to interpret multiple ECGs daily.
Hospitals use Cardiomatics in emergency departments and cardiac units to speed up rhythm disorder detection and initiate timely interventions.
The platform is also used in telemedicine and remote monitoring, where patients wear portable ECG devices at home and clinicians review the results remotely via Cardiomatics.
Research institutions and clinical trial teams use Cardiomatics to analyze large volumes of ECG data with high consistency and reproducibility, supporting faster study outcomes.
Pricing
Cardiomatics does not publicly list fixed pricing on its website. Pricing is typically customized based on volume, institution size, and integration needs.
The platform offers flexible licensing models, including pay-per-report, monthly subscriptions, and enterprise agreements for larger hospitals or research institutions.
Clinics and hospitals interested in using Cardiomatics can request a demo or pricing proposal directly through the company’s website. Free trial periods and pilot programs may be available for evaluation.
Strengths
A key strength of Cardiomatics is its speed and accuracy. The platform can analyze a 24-hour Holter recording in just minutes, helping clinicians diagnose conditions faster than manual interpretation would allow.
Cardiomatics’ device compatibility allows it to integrate easily into existing workflows without requiring investment in new hardware.
The comprehensive reporting provided by the platform includes detailed statistics and arrhythmia detection, reducing the risk of oversight and enabling better clinical decisions.
Its cloud-based architecture supports remote access and collaboration, making it ideal for telemedicine, distributed teams, or multi-site health systems.
Cardiomatics is clinically validated and CE-certified, which assures users of its reliability and adherence to medical safety standards.
Drawbacks
One potential drawback is that Cardiomatics is designed primarily for clinical use by trained professionals. It is not intended for direct consumer use or self-diagnosis.
Users still need to interpret AI-generated reports with clinical oversight, as the system does not replace the role of a cardiologist or physician.
The platform requires internet connectivity and data upload, which may be a challenge in low-bandwidth environments or in rural clinics with limited infrastructure.
Although it works with most devices, some legacy ECG systems may not be compatible, requiring file format conversion or third-party tools.
Comparison with Other Tools
Cardiomatics competes with other AI ECG platforms like AliveCor’s KardiaPro, Eko Health, and QT Medical. Compared to AliveCor, which is primarily focused on mobile ECGs for consumer use, Cardiomatics is built for clinical and professional environments, offering deeper analytics and report customization.
Eko Health combines stethoscope functionality with ECG, while Cardiomatics focuses solely on advanced ECG interpretation at scale, especially for Holter data and long-term monitoring.
QT Medical offers 12-lead ECG devices for at-home use, while Cardiomatics is device-agnostic and software-centric, making it a flexible solution for various practice types and institutions.
Its cloud-first, AI-driven workflow makes Cardiomatics a competitive option for healthcare providers looking to improve ECG turnaround time and accuracy without adding clinical burden.
Customer Reviews and Testimonials
Cardiomatics is used by more than 1,000 healthcare professionals across 15+ countries. Clinicians praise the platform for its user-friendly interface, fast analysis, and reliable results.
Users have reported significant time savings, with some clinics cutting ECG analysis time by more than 70%. Cardiologists appreciate the platform’s ability to highlight critical findings, reducing the chance of missed arrhythmias.
Healthcare administrators value the system’s cost-effectiveness and scalability, particularly when handling large volumes of Holter recordings or integrating with remote monitoring programs.
Testimonials highlight improved patient care due to quicker diagnoses, as well as smoother workflows and better collaboration among care teams.
Conclusion
Cardiomatics is a leading AI-powered ECG analysis platform designed to help healthcare professionals diagnose heart rhythm disorders faster and more accurately. Its cloud-based infrastructure, device flexibility, and clinical-grade performance make it an essential tool for modern cardiology and general practice.
With growing adoption across clinics, hospitals, and research institutions, Cardiomatics is reshaping how ECG data is processed and utilized in everyday care. By saving time, reducing manual workload, and increasing diagnostic accuracy, it supports better outcomes for patients and more efficient care delivery for providers.
